APO 009 Pill - blue & white capsule/oblong, 22mm
Pill with imprint APO 009 is Blue & White, Capsule/Oblong and has been identified as Dilt-CD Diltiazem 240 mg. It is supplied by Apotex Corp.
Diltiazem is used in the treatment of Atrial Fibrillation; Atrial Flutter; Heart Failure; High Blood Pressure; Angina Pectoris Prophylaxis and belongs to the drug classes calcium channel blockers, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem Diltiazem 240 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO 009
Dilt-CD
- Imprint
- APO 009
- Strength
- Diltiazem 240 mg
- Color
- Blue & White
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcium channel blockers, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- National Drug Code (NDC)
- 60505-0009 (Discontinued)
- Inactive Ingredients
-
dibutyl phthalate,
ammonio methacrylate copolymer type B,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
methylcellulose (15 mPa.s),
microcrystalline cellulose,
polysorbate 80,
magnesium silicate,
triethyl citrate,
gelatin,
titanium dioxide,
FD&C Blue No. 1,
ammonia,
ferrosoferric oxide,
potassium hydroxide,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Related images for "APO 009"
More about diltiazem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (192)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: calcium channel blockers
- Breastfeeding
Patient resources
Other brands
Cardizem, Cartia XT, Dilt-XR, Matzim LA, ... +5 more
Professional resources
- Diltiazem Hydrochloride monograph
- Diltiazem (FDA)
- Diltiazem CD (FDA)
- Diltiazem Extended Release Tablets (FDA)
- Diltiazem Injection (FDA)
- Diltiazem Tablets (FDA)
Other brands
Cardizem, Cartia XT, Dilt-XR, Tiadylt ER, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.